Poliovirus tropism and attenuation are determined after internal ribosome entry

Journal of Clinical Investigation

Volumn 113, Issue 12, 2004, Pages 1743-1753

  Kauder, Steven E ^a   Racaniello, Vincent R ^a  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NUCLEOTIDE; POLIOMYELITIS VACCINE; VIRUS RNA; ORAL POLIOMYELITIS VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; MOUSE; MUTATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARALYSIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; TRANSLATION INITIATION; VIRUS REPLICATION; VIRUS VIRULENCE; 5' UNTRANSLATED REGION; ADENOVIRUS; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; CONFORMATION; ENTEROVIRUS; GENETICS; HEPATITIS C VIRUS; METABOLISM; PATHOGENICITY; PHYSIOLOGY; POLIOMYELITIS; PROTEIN SYNTHESIS; REGULATORY SEQUENCE; RIBOSOME; SURVIVAL RATE;

5' UNTRANSLATED REGIONS; ADENOVIRIDAE; ANIMALS; CELL LINE; ENTEROVIRUS B, HUMAN; HEPACIVIRUS; HUMANS; MICE; MICE, INBRED C57BL; NUCLEIC ACID CONFORMATION; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; PROTEIN BIOSYNTHESIS; REGULATORY SEQUENCES, NUCLEIC ACID; RIBOSOMES; RNA, VIRAL; SURVIVAL RATE; VIRUS REPLICATION;

EID: 3042844141     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421323     Document Type: Article

References (64)

1. Kozak, M. 1979. Inability of circular mRNA to attach to eukaryotic ribosomes. Nature. 280:82-85.
2. Both, G.W., Furuichi, Y., Muthukrishnan, S., and Shatkin, A.J. 1975. Ribosome binding to reovirus mRNA in protein synthesis requires 5′ terminal 7-methylguanosine. Cell. 6:185-195.
3. Jang, S.K., et al. 1988. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62:2636-2643.
4. Holcik, M., Sonenberg, N., and Korneluk, R.G. 2000. Internal ribosome initiation of translation and the control of cell death. Trends Genet. 16:469-473.
5. Belsham, G.J., and Sonenberg, N. 1996. RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol. Rev. 60:499-511.
6. Brasey, A., et al. 2003. The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J. Virol. 77:3939-3949.
7. Hellen, C.U., and Sarnow, P. 2001. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 15:1593-1612.
8. Pelletier, J., Kaplan, G., Racaniello, V.R., and Sonenberg, N. 1988. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5′ noncoding region. Mol. Cell. Biol. 8:1103-1112.
9. Hewlett, M.J., Rose, J.K., and Baltimore, D. 1976. 5′-Terminal structure of poliovirus polyribosomal RNA is pUp. Proc. Natl. Acad. Sci. U. S. A. 73:327-330.
10. Nomoto, A., Lee, Y.F., and Wimmer, E. 1976. The 5′ end of poliovirus mRNA is not capped with m7G(5′)ppp(5′)Np. Proc. Natl. Acad. Sci. U. S. A. 73:375-380.
11. Ohka, S., and Nomoto, A. 2001. The molecular basis of poliovirus neurovirulence. Dev. Biol. (Basel). 105:51-58.
12. Gromeier, M., Alexander, L., and Wimmer, E. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc. Natl. Acad. Sci. U. S. A. 93:2370-2375.
13. Yanagiya, A., et al. 2003. Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor. J. Virol. 77:10479-10487.
14. Borman, A.M., Le Mercier, P., Girard, M., and Kean, K.M. 1997. Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res. 25:925-932.
15. Bodian, D.M. 1959. Poliomyelitis: pathogenesis and histopathology. In Viral and rickettsial infections of man. T.M. Rivers and F.L. Horsfall, editors. J.B. Lippincott Co. Philadelphia, Pennsylvania, USA. 479-498.
16. Mendelsohn, C.L., Wimmer, E., and Racaniello, V.R. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 56:855-865.
17. Freistadt, M.S., Kaplan, G., and Racaniello, V.R. 1990. Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol. Cell. Biol. 10:5700-5706.
18. Ren, R., and Racaniello, V.R. 1992. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 66:296-304.
19. Belsham, G.J., and Sonenberg, N. 2000. Picornavirus RNA translation: roles for cellular proteins. Trends Microbiol. 8:330-335.
20. Lu, H.H., and Wimmer, E. 1996. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 93:1412-1417.
21. Sabin, A.B., Hennessen, W.A., and Winsser, J. 1954. Studies on variants of poliomyelitis virus. J. Exp. Med. 99:551-576.
22. Kawamura, N., et al. 1989. Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 63:1302-1309.
23. Evans, D.M., et al. 1985. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 314:548-550.
24. Ren, R.B., Moss, E.G., and Racaniello, V.R. 1991. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65:1377-1382.
25. Westrop, G.D., et al. 1989. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J. Virol. 63:1338-1344.
26. La Monica, N., Almond, J.W., and Racaniello, V.R. 1987. A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J. Virol. 61:2917-2920.
27. Gutierrez, A.L., Denova-Ocampo, M., Racaniello, V.R., and del Angel, R.M. 1997. Attenuating mutations in the poliovirus 5′ untranslated region alter its interaction with polypyrimidine tract-binding protein. J. Virol. 71:3826-3833.
28. Svitkin, Y.V., Cammack, N., Minor, P.D., and Almond, J.W. 1990. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472-U. Virology. 175:103-109.
29. Haller, A.A., Stewart, S.R., and Semler, B.L. 1996. Attenuation stem-loop lesions in the 5′ noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J. Virol. 70:1467-1474.
30. La Monica, N., and Racaniello, V.R. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 63:2357-2360.
31. Wang, C., Sarnow, P., and Siddiqui, A. 1993. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 67:3338-3344.
32. Yang, D., et al. 1997. In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5′ untranslated region of coxsackievirus B3: potential targets for antiviral action of antisense oligomers. Virology. 229:63-73.
33. Haller, A.A., and Semler, B.L. 1992. Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA. J. Virol. 66:5075-5086.
34. Honda, M., et al. 1996. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology. 222:31-42.
35. Addison, C.L., Hitt, M., Kunsken, D., and Graham, F.L. 1997. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol. 78:1653-1661.
36. Hoofnagle, J.H. 1997. Hepatitis C: the clinical spectrum of disease. Hepatology. 26(Suppl. 1):15S-20S.
37. Kandolf, R., et al. 1993. Molecular mechanisms in the pathogenesis of enteroviral heart disease: acute and persistent infections. Clin. Immunol. Immunopathol. 68:153-158.
38. Shiroki, K., et al. 1995. A new cis-acting element for RNA replication within the 5′ noncoding region of poliovirus type 1 RNA. J. Virol. 69:6825-6832.
39. Borman, A.M., Deliat, F.G., and Kean, K.M. 1994. Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J. 13:3149-3157.
40. Ren, R.B., Costantini, F., Gorgacz, E.J., Lee, J.J., and Racaniello, V.R. 1990. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 63:353-362.
41. Khatib, R., Chason, J.L., Silberberg, B.K., and Lerner, A.M. 1980. Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J. Infect. Dis. 141:394-403.
42. Tracy, S., et al. 2000. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J. Med. Virol. 62:70-81.
43. Dorsam, V., et al. 2000. Increased safety level of serotype 3 Sabin oral poliomyelitis vaccine lots by improved seed virus, and tissue culture and virus infection conditions. Vaccine. 18:2435-2443.
44. Chumakov, K.M., Powers, L.B., Noonan, K.E., Roninson, I.B., and Levenbook, I.S. 1991. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl. Acad. Sci. U. S. A. 88:199-203.
45. Macadam, A.J., et al. 1994. Role for poliovirus protease 2A in cap independent translation. EMBO J. 13:924-927.
46. Skinner, M.A., et al. 1989. New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J. Mol. Biol. 207:379-392.
47. del Angel, R.M., Papavassiliou, A.G., Fernandez-Tomas, C., Silverstein, S.J., and Racaniello, V.R. 1989. Cell proteins bind to multiple sites within the 5′ untranslated region of poliovirus RNA. Proc. Natl. Acad. Sci. U. S. A. 86:8299-8303.
48. Enders, J.F., Weller, T.H., and Robbins, F.C. 1949. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science. 109:85-87.
49. Creancier, L., Morello, D., Mercier, P., and Prats, A.C. 2000. Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J. Cell Biol. 150:275-281.
50. Shaw-Jackson, C., and Michiels, T. 1999. Absence of internal ribosome entry site-mediated tissue specificity in the translation of a bicistronic transgene. J. Virol. 73:2729-2738.
51. Koike, S., et al. 1991. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. U. S. A. 88:951-955.
52. Zhang, S., and Racaniello, V.R. 1997. Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J. Virol. 71:4915-4920.
53. Zhao, W.D., Wimmer, E., and Lahser, F.C. 1999. Poliovirus/Hepatitis C virus (internal ribosomal entry site-core) chimeric viruses: improved growth properties through modification of a proteolytic cleavage site and requirement for core RNA sequences but not for core-related polypeptides. J. Virol. 73:1546-1554.
54. Lewis, J., Wesselingh, S.L., Griffin, D.E., and Hardwick, J.M. 1996. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J. Virol. 70:1828-1835.
55. Lawrence, D.M., Vaughn, M.M., Belman, A.R., Cole, J.S., and Rall, G.F. 1999. Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J. Virol. 73:1795-1801.
56. Crotty, S., Hix, L., Sigal, L.J., and Andino, R. 2002. Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection. J. Gen. Virol. 83:1707-1720.
57. Agol, V.I., et al. 1989. Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J. Virol. 63:4034-4038.
58. Wimmer, E., Hellen, C.U., and Cao, X. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353-436.
59. Minor, P.D. 1997. Poliovirus. In Viral pathogenesis. N. Nathanson, editor. Lippincott Williams & Wilkins - Raven Press. Philadelphia, Pennsylvania, USA. 555-574.
60. Tracy, S., Chapman, N.M., and Tu, Z. 1992. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch. Virol. 122:399-409.
61. Ausubel, F.M., et al., editors. 1987. Current protocols in molecular biology. John Wiley & Sons Inc. Hoboken, New Jersey, USA. 4.9.1-4.9.4.
62. Sambrook, J., Russell, D.W., Irwin, N., and Janssen, K.A. 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 9.4-9.8.
63. Reed, L.J., and Muench, H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
64. Kamoshita, N., Tsukiyama-Kohara, K., Kohara, M., and Nomoto, A. 1997. Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors. Virology. 233:9-18.